Last reviewed · How we verify
NCT04187027
Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele
NA trial testing pulsed electromagnetic field therapy device in Neurogenic Bladder in 40 participants. Participants enrolled and being followed up; not accepting new ones.
19 November 2025
Quick facts
| Lead sponsor | South Valley University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 27 May 2025 |
| Primary completion | 19 November 2025 |
| Estimated completion | 10 December 2025 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- pulsed electromagnetic field therapy device
Conditions studied
- Neurogenic Bladder — all drugs for Neurogenic Bladder →
Sponsor
South Valley University
Who can join
Adults 4 to 12, any sex, with Neurogenic Bladder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to assess the efficacy of pulsed electromagnetic field therapy on neurogenic bladder in children with myelomeningocele .Intervention: A pretest-post test controlled study was conducted in out-patient clinic in faculty of physical therapy Cairo university.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04187027
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurogenic Bladder
Currently open trials in the same condition.
- NCT07308808 — Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation · EARLY_PHASE1 · recruiting
- NCT04791579 — Antibiotic Prophylaxis for Neurogenic Bladder Botox · Phase 2 · recruiting
- NCT06515223 — Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury · NA · recruiting
- NCT06163469 — Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healt · NA · recruiting
- NCT06072703 — Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS · NA · recruiting
Other South Valley University trials
Trials by the same sponsor.
- NCT07478718 — Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy · NA · not yet recruiting
- NCT07265154 — Gait Training and Artificial Intelligence · NA · recruiting
- NCT07070544 — Effect of Electromagnetic Field Therapy and Customized Foot Insole on Peripheral Circulation and Ankle-Brachial Pressure · NA · not yet recruiting
- NCT07128472 — Evaluation of IL 12B Genetic Polymorphism (rs3213094) · NA · recruiting
- NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04187027 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by South Valley University
- Last refreshed: 15 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04187027.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing